Dhwani Mehta is a Dermatology physician affiliated with Concord Consortium. OpenAlex indexes 20 publications with 248 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
335 Penny Ln
Concord, NC 280251221
Telephone
704-784-5901Registry record last updated 29 May 2019.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year20258 payments
- ABBVIE INC.Program year202520 payments
- Arcutis Biotherapeutics, Inc.Program year202510 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
26.7%Azole Antifungal9%Ketoconazole86%Fluconazole14%Part D<11 patientsHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor5.4%Valacyclovir100%Part D≥28 patients+ 4 more classes in this area
Dermatology
21.1%Corticosteroid17.7%Triamcinolone Acetonide100%Part D≥146 patientsOther antifungals for topical use2.2%Ciclopirox100%Part D≥14 patients+ 1 more class in this area
Sensory organs
20.7%Corticosteroid20.7%Clobetasol Propionate47%Hydrocortisone41%Betamethasone Dipropionate11%Part D≥62 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The ambit of congenital malformations in the Kachchh district- a hospital-based study at a tertiary care center
Obsgyne Review Journal of Obstetric and Gynecology
2020 - S2061 Delayed Presentation of Small Bowel Obstruction in a Roux-en-Y Biliopancreatic Limb
The American Journal of Gastroenterology
2020 - Effect of combination <scp>NSAID</scp> and <scp>NBUVB</scp> treatment in non‐photoadapters—A pilot study
Photodermatology Photoimmunology & Photomedicine
2019 - Two-sided risk in the Oncology Care Model.
PubMed
2019 - Ectopic tales of kachcch: A study of ectopic pregnancies
International Journal of Clinical Obstetrics and Gynaecology
2019
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”